Growth Metrics

Tenax Therapeutics (TENX) Current Assets: 2011-2017

Historic Current Assets for Tenax Therapeutics (TENX) over the last 4 years, with Sep 2017 value amounting to $8.7 million.

  • Tenax Therapeutics' Current Assets rose 12.99% to $8.7 million in Q3 2017 from the same period last year, while for Sep 2017 it was $8.7 million, marking a year-over-year increase of 12.99%. This contributed to the annual value of $13.6 million for FY2016, which is N/A change from last year.
  • According to the latest figures from Q3 2017, Tenax Therapeutics' Current Assets is $8.7 million, which was down 3.71% from $9.0 million recorded in Q2 2017.
  • Over the past 5 years, Tenax Therapeutics' Current Assets peaked at $20.6 million during Q4 2015, and registered a low of $1.7 million during Q1 2013.
  • Over the past 3 years, Tenax Therapeutics' median Current Assets value was $10.2 million (recorded in 2016), while the average stood at $11.8 million.
  • In the last 5 years, Tenax Therapeutics' Current Assets tumbled by 61.87% in 2013 and then grew by 12.99% in 2017.
  • Tenax Therapeutics' Current Assets (Quarterly) stood at $1.8 million in 2013, then reached $20.6 million in 2015, then plummeted by 33.72% to $13.6 million in 2016, then rose by 12.99% to $8.7 million in 2017.
  • Its last three reported values are $8.7 million in Q3 2017, $9.0 million for Q2 2017, and $12.8 million during Q1 2017.